Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01169038 · ClinicalTrials.gov registry record · Phase 1
Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis
A Phase 1 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT01169038 is a Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 15 participants.
The verdict
NCT01169038, a Phase 1 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
Sarcoidosis is a granulomatous disease for which the molecular and immunologic association with mycobacteria continues to strengthen. The investigators are interested in conducting a proof-of-concept investigation of the effects of antibiotics on sarcoidosis resolution. The investigators hypothesize that pulmonary sarcoidosis will improve faster if patients are given antimycobacterial therapy, in addition to their standard therapy.
Interventions
- DRUG levaquin; ethambutol; rifampin and azithromycin.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2010-07 |
| Est. Completion | 2010-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01169038
The ClinicalTrials.gov registry entry for NCT01169038 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which levaquin; ethambutol; rifampin and azithromycin. is the first listed.
NCT01169038 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01169038 about?
NCT01169038 is a clinical study titled "Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis". Sarcoidosis is a granulomatous disease for which the molecular and immunologic association with mycobacteria continues to strengthen. The investigators are interested in conducting a proof-of-concept investigation of the effects of antibiotics on sarcoidosis resolution. The investigators hypothesize...
What is the current status of trial NCT01169038?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2010-07. Estimated completion is 2010-11.
What interventions are being tested in trial NCT01169038?
The interventions under investigation include: levaquin; ethambutol; rifampin and azithromycin. (DRUG).
Who is sponsoring clinical trial NCT01169038?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.